Hirdetés

Új hozzászólás Aktív témák

  • Ringman

    nagyúr

    válasz Parci #64032 üzenetére

    az orosz vakcina lehet jó, csak a phase3 trial eredményei kérdésesek:

    NYT covid vaccine tracker
    On Nov. 11, the Russian Direct Investment Fund announced preliminary evidence from their Phase 3 trial indicating that the vaccine is effective. Based on 20 cases of Covid-19 among the trial participants, Russian scientists estimated that the vaccine demonstrated 92 percent efficacy. On Nov. 24, the vaccine makers followed up with an analysis on 39 cases that pointed to the same efficacy rate. They also claimed that a preliminary analysis on some volunteers who had the vaccine for a longer period of time showed a 95 percent efficacy rate, but outside experts questioned that conclusion. As with the three other vaccines with announcements of Phase 3 efficacy — AstraZeneca, Moderna, and Pfizer — the Gamaleya Research Institute has yet to publish their latest findings in a peer-reviewed scientific journal.

    ---
    majd a békemenet beadhatja magának, biztos jobban megbíznak ebben, mint imperialista oltásokban.

Új hozzászólás Aktív témák